FI903706A0 - Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi

Info

Publication number
FI903706A0
FI903706A0 FI903706A FI903706A FI903706A0 FI 903706 A0 FI903706 A0 FI 903706A0 FI 903706 A FI903706 A FI 903706A FI 903706 A FI903706 A FI 903706A FI 903706 A0 FI903706 A0 FI 903706A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically active
cyclosporine derivatives
active cyclosporine
derivatives
Prior art date
Application number
FI903706A
Other languages
English (en)
Swedish (sv)
Other versions
FI94355B (fi
FI94355C (fi
Inventor
Marcel Karl Eberle
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI903706A0 publication Critical patent/FI903706A0/fi
Publication of FI94355B publication Critical patent/FI94355B/fi
Application granted granted Critical
Publication of FI94355C publication Critical patent/FI94355C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI903706A 1989-07-24 1990-07-23 Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi FI94355C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8916901 1989-07-24
GB898916901A GB8916901D0 (en) 1989-07-24 1989-07-24 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
FI903706A0 true FI903706A0 (fi) 1990-07-23
FI94355B FI94355B (fi) 1995-05-15
FI94355C FI94355C (fi) 1995-08-25

Family

ID=10660543

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903706A FI94355C (fi) 1989-07-24 1990-07-23 Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi

Country Status (23)

Country Link
EP (1) EP0414632B1 (fi)
JP (1) JPH0730113B2 (fi)
KR (1) KR100201174B1 (fi)
AT (1) ATE144536T1 (fi)
AU (1) AU631667B2 (fi)
CA (1) CA2021788C (fi)
CZ (1) CZ411691A3 (fi)
DE (1) DE69028967T2 (fi)
DK (1) DK0414632T3 (fi)
ES (1) ES2092500T3 (fi)
FI (1) FI94355C (fi)
GB (1) GB8916901D0 (fi)
GR (1) GR3021667T3 (fi)
HK (1) HK1004268A1 (fi)
HU (1) HU206127B (fi)
IE (1) IE902669A1 (fi)
IL (1) IL95154A (fi)
MY (1) MY105942A (fi)
NZ (1) NZ234613A (fi)
PT (1) PT94790B (fi)
SA (1) SA91110205B1 (fi)
SK (1) SK411691A3 (fi)
ZA (1) ZA905823B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
GB9204466D0 (en) * 1992-03-02 1992-04-15 Sandoz Ltd Improvements in or relating to organic compounds
US5482850A (en) * 1993-10-29 1996-01-09 New England Biolabs, Inc. Method for identifying anti-parasitic compounds
WO1997011092A1 (fr) * 1994-04-07 1997-03-27 Nippon Shinyaku Co., Ltd. Derives de phosphates de cyclosporine et composition medicinale
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100465012B1 (ko) 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
ES2326040T3 (es) 2001-10-19 2009-09-29 Isotechnika Inc. Sintesis de analogos de ciclosporina.
KR100865211B1 (ko) * 2001-10-26 2008-10-23 주식회사 엘지생활건강 비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en) 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
KR100439467B1 (ko) * 2002-11-13 2004-07-09 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
JP6204921B2 (ja) * 2011-11-15 2017-09-27 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンａの形態２およびその作製方法
WO2020037530A1 (en) 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN118184532A (zh) * 2018-12-12 2024-06-14 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (fi) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
DE3167014D1 (en) 1980-02-14 1984-12-13 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
DE3260468D1 (en) 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0314861A1 (en) 1984-10-04 1989-05-10 Sandoz Ag Labeled derivatives of cyclosporins
US4798823A (en) 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
DE3884470T2 (de) * 1987-06-17 1994-03-10 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel.
GB2206119B (en) 1987-06-22 1990-10-31 Merck & Co Inc A new cyclosporin derivative with modified "8-amino acid"
GB8717299D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Peptides
GB8717300D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
GB2207678A (en) 1987-08-03 1989-02-08 Merck & Co Inc Novel immunosuppressive fluorinated cyclosporin analogs
HU205010B (en) 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물

Also Published As

Publication number Publication date
IL95154A0 (en) 1991-06-10
KR910002902A (ko) 1991-02-26
HU904224D0 (en) 1990-12-28
PT94790A (pt) 1991-03-20
IE902669A1 (en) 1991-02-27
HK1004268A1 (en) 1998-11-20
NZ234613A (en) 1992-09-25
PT94790B (pt) 1997-04-30
SK411691A3 (en) 1995-07-11
JPH0730113B2 (ja) 1995-04-05
EP0414632A3 (en) 1991-09-11
GR3021667T3 (en) 1997-02-28
ES2092500T3 (es) 1996-12-01
FI94355B (fi) 1995-05-15
AU631667B2 (en) 1992-12-03
JPH03218396A (ja) 1991-09-25
DK0414632T3 (da) 1996-11-25
DE69028967T2 (de) 1997-05-15
CA2021788A1 (en) 1991-01-25
AU5972790A (en) 1991-01-24
EP0414632A2 (en) 1991-02-27
FI94355C (fi) 1995-08-25
HU206127B (en) 1992-08-28
KR100201174B1 (ko) 1999-06-15
HUT54714A (en) 1991-03-28
DE69028967D1 (de) 1996-11-28
IL95154A (en) 1995-03-30
SA91110205B1 (ar) 2004-08-07
MY105942A (en) 1995-02-28
CZ411691A3 (cs) 1998-06-17
ZA905823B (en) 1992-03-25
CA2021788C (en) 2001-02-13
EP0414632B1 (en) 1996-10-23
ATE144536T1 (de) 1996-11-15
GB8916901D0 (en) 1989-09-06

Similar Documents

Publication Publication Date Title
FI903706A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
NO178401C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-heteroaryl-triazolo-[1,5-aÅ[1,3,5Åtriaziner og -pyrazolo[2,3-aÅ[1,3,5Åtriaziner og nye mellomprodukter for fremstilling derav
HUT53369A (en) Process for producing substituted pyrrole and pharmaceutical compositions containing them
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
EP0768312A3 (en) Bis-Staurosporine and K-252a derivatives
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
AU7370491A (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
CA2019404A1 (en) 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
FI885153A (fi) Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi
MA22906A1 (fr) Derives nouveaux de pyrazole substitues sur l'azote, leur procede de production, compositions les contenant et leur utilisation comme herbicides.
GR3006366T3 (fi)
FR2484418B1 (fr) Nouveaux derives d'acide isocyanurique, utiles notamment comme agents cytostatiques, et leur procede de preparation
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
HU911982D0 (en) Pesticide preparations containing 2-metoximino-carbonic acid esther derivatives and process for the production of the active agents
FR2621588B1 (fr) Nouveaux derives de la 1,1-dioxo 1,2-benzoisothiazol 3-one, leur procede de preparation et leur application comme medicaments
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
FR2632952B1 (fr) Procede de preparation d'isocyanates d'arylsulfonyle et des derives d'addition en resultant
ATE18404T1 (de) Thiazolo(2,3-b)-chinazolone und verfahren zu ihrer herstellung.
HU913326D0 (en) Herbicide preparations containing triazolo-piridazine-derivatives as active agents and process for the production of the active agents
HU903015D0 (en) Herbicide preparations containing diazepin as active agent and process for the production of the herbicide active agent
FR2608153B1 (fr) Di-bishydroxypropyle de l'acide cyanurique, ses derives trisubstitues et leur procede de fabrication
YU45190A (en) Process and an intermediate for preparing 1,3-substituted esther of tetrahydro-1h-thieno-/3,4-d/-imidazol-2-(3h)-on-4-iliden-pentanic acid

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired